Edesa Biotech (EDSA) Capital Expenditures (2013 - 2022)
Edesa Biotech's Capital Expenditures came in at -$41.00 for fiscal Q4 2022 (quarter ended Sep 30, 2022), compared with -$1,464 a year earlier.
Edesa Biotech (EDSA) Capital Expenditures (2013 - 2022) Analysis & Trends
For FY2022 (ended Sep 30, 2022), Edesa Biotech's Capital Expenditures was $5,656, down 8.0% from FY2021.
- Capital Expenditures carries a five-year compound annual growth rate of -54.9% (FY2017 to FY2022).
- Going back by fiscal year, Capital Expenditures was $6,146 in FY2021 (-79.2%), $29,483 in FY2020 (+264.2%), $8,095 in FY2019 (-97.9%) and $382,810 in FY2018 (+26.5%).
- The five-year range for quarterly Capital Expenditures is -$1,464 (fiscal Q4 2021) to $171,124 (fiscal Q2 2018).
- Year-over-year, Capital Expenditures increased in two of the last four quarters, with growth averaging 78.7%.
- The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q2 2018 (growth of 303.1%), and the weakest in fiscal Q3 2018 (a decline of 90.7%).
- Business Quant data shows EDSA's Capital Expenditures at $1,358 (Q3 2022), $1,199 (Q2 2022) and $3,140 (Q1 2022) in the three fiscal quarters before Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Edesa Biotech | 40.56 Mn | 40.56 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -41.00 |
| Jun 30, 2022 | 1,358.00 |
| Mar 31, 2022 | 1,199.00 |
| Dec 31, 2021 | 3,140.00 |
| Sep 30, 2021 | -1,464.00 |
| Jun 30, 2021 | 3,512.00 |
| Mar 31, 2021 | 2,963.00 |
| Dec 31, 2020 | 1,135.00 |
| Jun 30, 2020 | 28,658.00 |
| Mar 31, 2020 | 825.00 |
| Dec 31, 2018 | 5,666.00 |
| Sep 30, 2018 | 21,410.00 |
| Jun 30, 2018 | 155,509.00 |
| Mar 31, 2018 | 171,124.00 |
| Dec 31, 2017 | 34,767.00 |
| Sep 30, 2017 | 102,368.00 |
| Jun 30, 2017 | 73,489.00 |
| Mar 31, 2017 | 42,452.00 |
| Dec 31, 2016 | 84,424.00 |
| Sep 30, 2016 | 107,413.00 |
Edesa Biotech Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EDSA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();